Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients

NCT07303296 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Leber Hereditary Optic Disease

Interventions

GENETIC: GS010 High dose
GENETIC: GS010 Low dose

Sponsor

GenSight Biologics